Loring Wolcott & Coolidge Fiduciary Advisors LLP Quest Diagnostics Inc Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 153 shares of DGX stock, worth $20,974. This represents 0.0% of its overall portfolio holdings.
Number of Shares
153
Previous 335
54.33%
Holding current value
$20,974
Previous $44,000
54.55%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DGX
# of Institutions
909Shares Held
96.1MCall Options Held
587KPut Options Held
235K-
Vanguard Group Inc Valley Forge, PA14MShares$1.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.19MShares$712 Million0.03% of portfolio
-
Victory Capital Management Inc3.88MShares$532 Million0.55% of portfolio
-
American Century Companies Inc Kansas City, MO2.85MShares$391 Million0.24% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...